Clinical studies of ischemic stroke are currently undergoing exciting changes, in particular with the ability of early onset treatment. Recently seminal examples of this have been published including the PHANTOM-S, MR CLEAN, and FAST-MAG studies. This provides an exciting perspective for new treatment of ischemic stroke.
Getting chemistry and biology to communicate
Copenhagen Spin-outs features an in-depth profile of Avilex Pharma and its CEO/CSO Kristian Strømgaard.